radison labs private

What radison labs private does

Radison Labs Private Limited (previously Radision Labs Pvt. Ltd.) is a privately held Indian bulk drug manufacturer founded in 2016 under the Companies Act 1956 and Drugs and Cosmetic Act 1940, headquartered in Hyderabad, Telangana with manufacturing operations in Humnabad, Bidar (Karnataka). The company manufactures Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates for the B2B pharmaceutical industry, currently commercializing APIs including Itraconazole (anti-fungal), Levocetirizine HCl (anti-histamine), Flurbiprofen (anti-inflammatory), and Risedronate Sodium (osteoporosis), with pipeline APIs in Fexofenadine HCl, Posaconazole, Paliperidone, and Risperidone. Underlying technology is rooted in management expertise in complex multi-step synthetic chemistry, supported by a GMP-WHO-GMP certified facility with regulatory identifiers including DUNS (860441796), FDA FEI (3016009965), and EMA SPOR (ORG-100051156), plus a documented Quality Management System.

The company's commercial model is direct B2B sales of APIs and intermediates to pharmaceutical manufacturers via quote-based, one-time transactions; pricing is not publicly disclosed. Its commercial intermediates portfolio spans Fexofenadine, Pazopanib, Valsartan, Bempedoic Acid, Tapinarof, Mirogabalin, Cariprazine, Vonoprazan, Bilastine, Finerenone, and Risperidone/Paliperidone/Iloperidone, alongside peptide coupling reagents (HATU, PyBOP, HOAt, HBTU, HOBt, TBTU) and raw materials for API synthesis. The company has been audited by ten enterprise Indian pharma buyers including Granules India, Mylan, Morepen Laboratories, Ind-Swift Laboratories, MSN Life Sciences, Macleods, ZCL & Cohance, Malladi Drugs, Lee Pharma, and Neuland Laboratories, indicating qualified-supplier status in the domestic market.

The regulatory strategy is the key forward-looking dimension: intermediates supplied to clients are already incorporated into CEP and US DMF filings, and Radison Labs is actively preparing its own API dossiers for US and European regulatory approval. With 27 employees and a single manufacturing site, the company is a focused, founder/management-owned specialty API/intermediate manufacturer with no external institutional investors, venture capital, or private equity exposure disclosed in the source data.

Name

radison labs private

Legal name

Radison Labs Private Limited

Website

https://radisonlabs.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Radison Labs Private Limited is an Indian B2B manufacturer of Active Pharmaceutical Ingredients and pharmaceutical intermediates, founded in 2016 and operating from Hyderabad with a GMP-WHO-GMP facility in Karnataka, supplying domestic and international pharmaceutical companies while pursuing US and EU regulatory approvals.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredient Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule API & Intermediates CDMO (HLAGABAA)

akta.pro secondary industries

Small-Molecule API Commercial Manufacturing (HLAGAHAB), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Active pharmaceutical ingredients
• Pharmaceutical intermediates
• Bulk drug manufacturing
• API contract manufacturing
• Custom synthesis chemicals

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. API Sales: Manufacturing and sale of Active Pharmaceutical Ingredients to pharmaceutical companies
2. Intermediate Sales: Manufacturing and sale of pharmaceutical intermediates to pharmaceutical companies for drug production
3. Custom Synthesis: Development and manufacture of specialty chemical products using sophisticated technology following national and international specifications

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Radison Labs Private Limited is a bulk drug manufacturer that produces Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates, including commercial APIs such as Itraconazole, Levocetirizine HCl, Flurbiprofen, and Risedronate Sodium, along with validated intermediates for drugs such as Fexofenadine, Pazopanib, Valsartan, Bempedoic Acid, Tapinarof, Cariprazine, Vonoprazan, and peptide coupling reagents. Output is manufactured under GMP-WHO-GMP certified facilities and supplied to pharmaceutical companies for incorporation into CEP and US DMF filings.

Product overview

Radison Labs Private Limited is a pharmaceutical manufacturing company established in 2016, engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company operates with a GMP-WHO-GMP certified facility and produces commercial APIs (Itraconazole, Levocetirizine HCl, Flurbiprofen, Risedronate Sodium) alongside an API pipeline (Fexofenadine HCl, Posoconazole, Paliperidone, Risperidone). The product portfolio encompasses pharmaceutical intermediates including those for Pazopanib, Valsartan, Bempedoic Acid, Cariprazine, and peptide coupling reagents (HATU, PyBOP, HOAt, HBTU), as well as raw materials for various API synthesis. The company supplies intermediates incorporated into CEP and US DMF filings, serving the global pharmaceutical industry.

Differentiator

Problem solved

Functional benefit

Products and services

• Itraconazole API Commercial Active Pharmaceutical Ingredient Itraconazole (CAS 84625-61-6), used as an anti-fungal, manufactured to USP/EP/BP/IP pharmacopeia standards for pharmaceutical companies.
• Levocetirizine HCl API Commercial Active Pharmaceutical Ingredient Levocetirizine HCl (CAS 130018-87-0), used as an anti-histamine, manufactured to USP/IP pharmacopeia standards for pharmaceutical companies.
• Flurbiprofen API Commercial Active Pharmaceutical Ingredient Flurbiprofen (CAS 5104-49-4), used as an anti-inflammatory, manufactured for pharmaceutical company buyers.
• Risedronate Sodium API Commercial Active Pharmaceutical Ingredient Risedronate Sodium (CAS 115436-72-1), used in osteoporosis treatment, manufactured for pharmaceutical company buyers.
• Pharmaceutical Intermediates Validated pharmaceutical intermediates supplied to pharmaceutical companies for drugs including Fexofenadine, Pazopanib, Valsartan, Bempedoic Acid, Tapinarof, Mirogabalin, Cariprazine, Vonoprazan, Bilastine, Finerenone, Risperidone/Paliperidone/Iloperidone, along with sulfonamides, pyrimidines, indoles, and other raw materials for API synthesis. Intermediates are already incorporated into clients' CEP and US DMF filings.
• Peptide Coupling Reagents Specialty chemical reagents used in peptide synthesis, including HATU, PyBOP, HOAt, HBTU, HOBt monohydrate, and TBTU with their respective CAS numbers.
• Custom Synthesis Services Development and manufacture of specialty chemical products using sophisticated technology, following national and international specifications, for pharmaceutical buyers requiring bespoke molecules.

Quantifiable outcome

• Intermediates incorporated into CEP and US DMF filings for regulatory compliance

Named customers10 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered minor.

• Granules IndiaminorOthersGranules India conducted a GMP audit of Radison Labs facility, indicating a supplier-auditor relationship where Granules India evaluated Radison Labs as a potential API/intermediate supplier.
• MylanminorOthersMylan conducted a GMP audit of Radison Labs facility, indicating a supplier evaluation relationship.
• Morepen LaboratoriesminorOthersMorepen Laboratories conducted a GMP audit of Radison Labs facility.
• Ind-Swift LaboratoriesminorOthersInd-Swift Laboratories conducted a GMP audit of Radison Labs facility.
• MSN Life SciencesminorOthersMSN Life Sciences conducted a GMP audit of Radison Labs facility.
• MacleodsminorOthersMacleods conducted a GMP audit of Radison Labs facility.
• ZCL & CohanceminorOthersZCL & Cohance conducted a GMP audit of Radison Labs facility.
• Malladi DrugsminorOthersMalladi Drugs conducted a GMP audit of Radison Labs facility.
• Lee PharmaminorOthersLee Pharma conducted a GMP audit of Radison Labs facility.
• Neuland LaboratoriesminorOthersNeuland Laboratories conducted a GMP audit of Radison Labs facility.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Morepen Laboratories: Indian API manufacturer with focus on intermediates and bulk actives for generic pharma. Similar product categories (anti-histamines, specialty actives) and customer overlap.
• Ind-Swift Laboratories: Chandigarh-based manufacturer of APIs and intermediates serving global generic and branded pharma. Comparable scale and product mix in small-molecule APIs, with audited-customer overlap at Radison.
• Neuland Laboratories: Hyderabad-based API and contract manufacturing organization with a similar focus on small-molecule APIs, intermediates, and CDMO services. Radison lists Neuland as an audited customer, underscoring direct comparability in product category and target customers.
• Malladi Drugs: Chennai-based API and intermediate manufacturer serving global pharma customers. Comparable in scope of small-molecule API manufacturing and audited-customer overlap with Radison.
• MSN Life Sciences: Indian API and intermediate manufacturer with active pharmaceutical ingredient portfolios and CDMO offerings. Overlapping capabilities in complex small-molecule chemistry and similar customer base among Indian and global generic manufacturers.
• Lee Pharma: Hyderabad-based API manufacturer with comparable product categories and customer base. Listed as an audited customer of Radison and operates in overlapping small-molecule API segments.

Broad incumbents

• Macleods Pharmaceuticals: Large vertically integrated Indian pharmaceutical company with internal API manufacturing and a global generic portfolio. Audited customer of Radison and broader incumbent competitor.
• Divis Laboratories: One of India's largest API and intermediate manufacturers with a global customer base across generics and nutraceuticals. Represents the scaled incumbent benchmark for CDMO/API competitors in the same molecule classes.
• Aurobindo Pharma: Vertically integrated Indian pharmaceutical major with extensive API manufacturing operations and US/EU regulatory infrastructure. Establishes the upper-scale competitive benchmark Radison must compete against.
• Granules India: Vertically integrated API and finished-dose manufacturer with global footprint and significant scale advantage. Listed as an audited customer of Radison, illustrating the broader competitive set Radison operates within.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/radison-labs-private

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about radison labs private